The life span of patients with primary and secondary immunodeficiency is increasing due to
recent improvements in therapeutic strategies. While the incidence of primary …

Tandem mass spectrometry (MS/MS) has become a leading technology used in clinical
chemistry and has shown to be particularly sensitive and specific when used in newborn …

Summary Members of the European Society for Immunodeficiencies (ESID) and other
colleagues have updated the multi-stage expert-opinion-based diagnostic protocol for non …

Background In the current context of high fatality rates associated with American visceral
leishmaniasis (VL), the appropriate use of prognostic factors to identify patients at higher risk …

Background Prenatal exposure to anti–tumor necrosis factor α (TNF-α) antibodies seems to
be safe for fetal development. Data on long-term outcome of exposed children are missing …

Paediatric respiratory tract infections are one of the most common reasons for physician
visits and hospitalisation, and are associated with significant morbidity and mortality …

Immunoglobulin replacement therapy (IRT) is standard treatment for patients with primary
immunodeficiency (PID). Because most of the patients with PID will require long life-time …

The sinopulmonary tract is the major site of infection in patients with primary antibody
deficiency syndromes, and structural lung damage arising from repeated sepsis is a major …

В структуре заболеваемости часто болеющих детей (ЧБД) преобладают повторные
инфекции верхних дыхательных путей (ВДП), у 10–15% ЧБД встречаются инфекции …

One in 2,000 children younger than 18 years is thought to have a primary immunodeficiency
disease. Antibody, combined B-cell and T-cell, phagocytic, and complement disorders are …